The Effect of Ruboxistaurin on Visual Loss in Patients With Moderately Severe to Very Severe Nonproliferative Diabetic Retinopathy: Initial Results of the Protein Kinase C β Inhibitor Diabetic Retinopathy Study (PKCDRS) Multicenter Randomized Clinical Trial